Research ArticleArticle
Factors Influencing Concordance Between Clinical and Ultrasound Findings in Rheumatoid Arthritis
Marion Le Boedec, Sandrine Jousse-Joulin, Jean-François Ferlet, Thierry Marhadour, Gérard Chales, Laurent Grange, Cécile Hacquard-Bouder, Damien Loeuille, Jérémie Sellam, Jean-David Albert, Jacques Bentin, Isabelle Chary-Valckenaere, Maria-Antonietta d'Agostino, Fabien Etchepare, Philippe Gaudin, Christophe Hudry, Maxime Dougados and Alain Saraux
The Journal of Rheumatology January 2013, jrheum.120843; DOI: https://doi.org/10.3899/jrheum.120843
Marion Le Boedec
From Rheumatology, Centre Hospitalier Universitaire (CHU) Brest, Brest; Statistics, RCTS, Lyon; Rheumatology, CHU, Rennes; Rheumatology, CHU, Grenoble; Rheumatology, APHP, Paris Boulogne; Rheumatology, CHU, Nancy; Rheumatology, CHU, Paris Saint Antoine; Rheumatology, CHU, Paris Boulogne; Rheumatology, CHU, Pitié, Paris; Rheumatology, APHP, Cochin, Paris, France; and Rheumatology, CHU, Brugmann, Belgium. Supported by an unrestricted grant from Abbott France. M. Le Boedec, MD; S. Jousse-Joulin, MD, Rheumatology, CHU Brest; JF. Ferlet, PhD, Statistics, RCTS; T. Marhadour, MD, Rheumatology, CHU Brest; G. Chales, MD, Rheumatology, CHU, Rennes; L. Grange, MD, Rheumatology, CHU, Grenoble; C. Hacquard-Bouder, MD, Rheumatology, APHP, Paris Boulogne; D. Loeuille, MD, PhD, Rheumatology, CHU, Nancy; J. Sellam, MD, PhD, Rheumatology, CHU, Paris Saint Antoine; J-D. Albert, MD, Rheumatology, CHU, Rennes; J. Bentin, MD, Rheumatology, CHU, Brugmann; I. Chary-Valckenaere, MD, PhD, Rheumatology, CHU, Nancy; M-A. d’Agostino, MD, PhD, Rheumatology, CHU, Paris Boulogne; F. Etchepare, MD, Rheumatology, CHU, Pitié, Paris; P. Gaudin, MD, PhD, Rheumatology, CHU, Grenoble; C. Hudry, MD; M. Dougados, MD, Rheumatology, APHP, Cochin, Paris; A. Saraux, MD, PhD, Rheumatology, CHU Brest. Dr. M. Le Boedec and Dr. S. Jousse-Joulin contributed equally to this report. Address correspondence to Prof. A. Saraux, Rheumatology Unit, la Cavale Blanche Hospital, Brest Teaching Hospital, BP 814, F 29609 Brest-Cedex, France. E-mail: Alain.Saraux@univ-brest.fr Accepted for publication November 27, 2012.
Sandrine Jousse-Joulin
From Rheumatology, Centre Hospitalier Universitaire (CHU) Brest, Brest; Statistics, RCTS, Lyon; Rheumatology, CHU, Rennes; Rheumatology, CHU, Grenoble; Rheumatology, APHP, Paris Boulogne; Rheumatology, CHU, Nancy; Rheumatology, CHU, Paris Saint Antoine; Rheumatology, CHU, Paris Boulogne; Rheumatology, CHU, Pitié, Paris; Rheumatology, APHP, Cochin, Paris, France; and Rheumatology, CHU, Brugmann, Belgium. Supported by an unrestricted grant from Abbott France. M. Le Boedec, MD; S. Jousse-Joulin, MD, Rheumatology, CHU Brest; JF. Ferlet, PhD, Statistics, RCTS; T. Marhadour, MD, Rheumatology, CHU Brest; G. Chales, MD, Rheumatology, CHU, Rennes; L. Grange, MD, Rheumatology, CHU, Grenoble; C. Hacquard-Bouder, MD, Rheumatology, APHP, Paris Boulogne; D. Loeuille, MD, PhD, Rheumatology, CHU, Nancy; J. Sellam, MD, PhD, Rheumatology, CHU, Paris Saint Antoine; J-D. Albert, MD, Rheumatology, CHU, Rennes; J. Bentin, MD, Rheumatology, CHU, Brugmann; I. Chary-Valckenaere, MD, PhD, Rheumatology, CHU, Nancy; M-A. d’Agostino, MD, PhD, Rheumatology, CHU, Paris Boulogne; F. Etchepare, MD, Rheumatology, CHU, Pitié, Paris; P. Gaudin, MD, PhD, Rheumatology, CHU, Grenoble; C. Hudry, MD; M. Dougados, MD, Rheumatology, APHP, Cochin, Paris; A. Saraux, MD, PhD, Rheumatology, CHU Brest. Dr. M. Le Boedec and Dr. S. Jousse-Joulin contributed equally to this report. Address correspondence to Prof. A. Saraux, Rheumatology Unit, la Cavale Blanche Hospital, Brest Teaching Hospital, BP 814, F 29609 Brest-Cedex, France. E-mail: Alain.Saraux@univ-brest.fr Accepted for publication November 27, 2012.
Jean-François Ferlet
From Rheumatology, Centre Hospitalier Universitaire (CHU) Brest, Brest; Statistics, RCTS, Lyon; Rheumatology, CHU, Rennes; Rheumatology, CHU, Grenoble; Rheumatology, APHP, Paris Boulogne; Rheumatology, CHU, Nancy; Rheumatology, CHU, Paris Saint Antoine; Rheumatology, CHU, Paris Boulogne; Rheumatology, CHU, Pitié, Paris; Rheumatology, APHP, Cochin, Paris, France; and Rheumatology, CHU, Brugmann, Belgium. Supported by an unrestricted grant from Abbott France. M. Le Boedec, MD; S. Jousse-Joulin, MD, Rheumatology, CHU Brest; JF. Ferlet, PhD, Statistics, RCTS; T. Marhadour, MD, Rheumatology, CHU Brest; G. Chales, MD, Rheumatology, CHU, Rennes; L. Grange, MD, Rheumatology, CHU, Grenoble; C. Hacquard-Bouder, MD, Rheumatology, APHP, Paris Boulogne; D. Loeuille, MD, PhD, Rheumatology, CHU, Nancy; J. Sellam, MD, PhD, Rheumatology, CHU, Paris Saint Antoine; J-D. Albert, MD, Rheumatology, CHU, Rennes; J. Bentin, MD, Rheumatology, CHU, Brugmann; I. Chary-Valckenaere, MD, PhD, Rheumatology, CHU, Nancy; M-A. d’Agostino, MD, PhD, Rheumatology, CHU, Paris Boulogne; F. Etchepare, MD, Rheumatology, CHU, Pitié, Paris; P. Gaudin, MD, PhD, Rheumatology, CHU, Grenoble; C. Hudry, MD; M. Dougados, MD, Rheumatology, APHP, Cochin, Paris; A. Saraux, MD, PhD, Rheumatology, CHU Brest. Dr. M. Le Boedec and Dr. S. Jousse-Joulin contributed equally to this report. Address correspondence to Prof. A. Saraux, Rheumatology Unit, la Cavale Blanche Hospital, Brest Teaching Hospital, BP 814, F 29609 Brest-Cedex, France. E-mail: Alain.Saraux@univ-brest.fr Accepted for publication November 27, 2012.
Thierry Marhadour
From Rheumatology, Centre Hospitalier Universitaire (CHU) Brest, Brest; Statistics, RCTS, Lyon; Rheumatology, CHU, Rennes; Rheumatology, CHU, Grenoble; Rheumatology, APHP, Paris Boulogne; Rheumatology, CHU, Nancy; Rheumatology, CHU, Paris Saint Antoine; Rheumatology, CHU, Paris Boulogne; Rheumatology, CHU, Pitié, Paris; Rheumatology, APHP, Cochin, Paris, France; and Rheumatology, CHU, Brugmann, Belgium. Supported by an unrestricted grant from Abbott France. M. Le Boedec, MD; S. Jousse-Joulin, MD, Rheumatology, CHU Brest; JF. Ferlet, PhD, Statistics, RCTS; T. Marhadour, MD, Rheumatology, CHU Brest; G. Chales, MD, Rheumatology, CHU, Rennes; L. Grange, MD, Rheumatology, CHU, Grenoble; C. Hacquard-Bouder, MD, Rheumatology, APHP, Paris Boulogne; D. Loeuille, MD, PhD, Rheumatology, CHU, Nancy; J. Sellam, MD, PhD, Rheumatology, CHU, Paris Saint Antoine; J-D. Albert, MD, Rheumatology, CHU, Rennes; J. Bentin, MD, Rheumatology, CHU, Brugmann; I. Chary-Valckenaere, MD, PhD, Rheumatology, CHU, Nancy; M-A. d’Agostino, MD, PhD, Rheumatology, CHU, Paris Boulogne; F. Etchepare, MD, Rheumatology, CHU, Pitié, Paris; P. Gaudin, MD, PhD, Rheumatology, CHU, Grenoble; C. Hudry, MD; M. Dougados, MD, Rheumatology, APHP, Cochin, Paris; A. Saraux, MD, PhD, Rheumatology, CHU Brest. Dr. M. Le Boedec and Dr. S. Jousse-Joulin contributed equally to this report. Address correspondence to Prof. A. Saraux, Rheumatology Unit, la Cavale Blanche Hospital, Brest Teaching Hospital, BP 814, F 29609 Brest-Cedex, France. E-mail: Alain.Saraux@univ-brest.fr Accepted for publication November 27, 2012.
Gérard Chales
From Rheumatology, Centre Hospitalier Universitaire (CHU) Brest, Brest; Statistics, RCTS, Lyon; Rheumatology, CHU, Rennes; Rheumatology, CHU, Grenoble; Rheumatology, APHP, Paris Boulogne; Rheumatology, CHU, Nancy; Rheumatology, CHU, Paris Saint Antoine; Rheumatology, CHU, Paris Boulogne; Rheumatology, CHU, Pitié, Paris; Rheumatology, APHP, Cochin, Paris, France; and Rheumatology, CHU, Brugmann, Belgium. Supported by an unrestricted grant from Abbott France. M. Le Boedec, MD; S. Jousse-Joulin, MD, Rheumatology, CHU Brest; JF. Ferlet, PhD, Statistics, RCTS; T. Marhadour, MD, Rheumatology, CHU Brest; G. Chales, MD, Rheumatology, CHU, Rennes; L. Grange, MD, Rheumatology, CHU, Grenoble; C. Hacquard-Bouder, MD, Rheumatology, APHP, Paris Boulogne; D. Loeuille, MD, PhD, Rheumatology, CHU, Nancy; J. Sellam, MD, PhD, Rheumatology, CHU, Paris Saint Antoine; J-D. Albert, MD, Rheumatology, CHU, Rennes; J. Bentin, MD, Rheumatology, CHU, Brugmann; I. Chary-Valckenaere, MD, PhD, Rheumatology, CHU, Nancy; M-A. d’Agostino, MD, PhD, Rheumatology, CHU, Paris Boulogne; F. Etchepare, MD, Rheumatology, CHU, Pitié, Paris; P. Gaudin, MD, PhD, Rheumatology, CHU, Grenoble; C. Hudry, MD; M. Dougados, MD, Rheumatology, APHP, Cochin, Paris; A. Saraux, MD, PhD, Rheumatology, CHU Brest. Dr. M. Le Boedec and Dr. S. Jousse-Joulin contributed equally to this report. Address correspondence to Prof. A. Saraux, Rheumatology Unit, la Cavale Blanche Hospital, Brest Teaching Hospital, BP 814, F 29609 Brest-Cedex, France. E-mail: Alain.Saraux@univ-brest.fr Accepted for publication November 27, 2012.
Laurent Grange
From Rheumatology, Centre Hospitalier Universitaire (CHU) Brest, Brest; Statistics, RCTS, Lyon; Rheumatology, CHU, Rennes; Rheumatology, CHU, Grenoble; Rheumatology, APHP, Paris Boulogne; Rheumatology, CHU, Nancy; Rheumatology, CHU, Paris Saint Antoine; Rheumatology, CHU, Paris Boulogne; Rheumatology, CHU, Pitié, Paris; Rheumatology, APHP, Cochin, Paris, France; and Rheumatology, CHU, Brugmann, Belgium. Supported by an unrestricted grant from Abbott France. M. Le Boedec, MD; S. Jousse-Joulin, MD, Rheumatology, CHU Brest; JF. Ferlet, PhD, Statistics, RCTS; T. Marhadour, MD, Rheumatology, CHU Brest; G. Chales, MD, Rheumatology, CHU, Rennes; L. Grange, MD, Rheumatology, CHU, Grenoble; C. Hacquard-Bouder, MD, Rheumatology, APHP, Paris Boulogne; D. Loeuille, MD, PhD, Rheumatology, CHU, Nancy; J. Sellam, MD, PhD, Rheumatology, CHU, Paris Saint Antoine; J-D. Albert, MD, Rheumatology, CHU, Rennes; J. Bentin, MD, Rheumatology, CHU, Brugmann; I. Chary-Valckenaere, MD, PhD, Rheumatology, CHU, Nancy; M-A. d’Agostino, MD, PhD, Rheumatology, CHU, Paris Boulogne; F. Etchepare, MD, Rheumatology, CHU, Pitié, Paris; P. Gaudin, MD, PhD, Rheumatology, CHU, Grenoble; C. Hudry, MD; M. Dougados, MD, Rheumatology, APHP, Cochin, Paris; A. Saraux, MD, PhD, Rheumatology, CHU Brest. Dr. M. Le Boedec and Dr. S. Jousse-Joulin contributed equally to this report. Address correspondence to Prof. A. Saraux, Rheumatology Unit, la Cavale Blanche Hospital, Brest Teaching Hospital, BP 814, F 29609 Brest-Cedex, France. E-mail: Alain.Saraux@univ-brest.fr Accepted for publication November 27, 2012.
Cécile Hacquard-Bouder
From Rheumatology, Centre Hospitalier Universitaire (CHU) Brest, Brest; Statistics, RCTS, Lyon; Rheumatology, CHU, Rennes; Rheumatology, CHU, Grenoble; Rheumatology, APHP, Paris Boulogne; Rheumatology, CHU, Nancy; Rheumatology, CHU, Paris Saint Antoine; Rheumatology, CHU, Paris Boulogne; Rheumatology, CHU, Pitié, Paris; Rheumatology, APHP, Cochin, Paris, France; and Rheumatology, CHU, Brugmann, Belgium. Supported by an unrestricted grant from Abbott France. M. Le Boedec, MD; S. Jousse-Joulin, MD, Rheumatology, CHU Brest; JF. Ferlet, PhD, Statistics, RCTS; T. Marhadour, MD, Rheumatology, CHU Brest; G. Chales, MD, Rheumatology, CHU, Rennes; L. Grange, MD, Rheumatology, CHU, Grenoble; C. Hacquard-Bouder, MD, Rheumatology, APHP, Paris Boulogne; D. Loeuille, MD, PhD, Rheumatology, CHU, Nancy; J. Sellam, MD, PhD, Rheumatology, CHU, Paris Saint Antoine; J-D. Albert, MD, Rheumatology, CHU, Rennes; J. Bentin, MD, Rheumatology, CHU, Brugmann; I. Chary-Valckenaere, MD, PhD, Rheumatology, CHU, Nancy; M-A. d’Agostino, MD, PhD, Rheumatology, CHU, Paris Boulogne; F. Etchepare, MD, Rheumatology, CHU, Pitié, Paris; P. Gaudin, MD, PhD, Rheumatology, CHU, Grenoble; C. Hudry, MD; M. Dougados, MD, Rheumatology, APHP, Cochin, Paris; A. Saraux, MD, PhD, Rheumatology, CHU Brest. Dr. M. Le Boedec and Dr. S. Jousse-Joulin contributed equally to this report. Address correspondence to Prof. A. Saraux, Rheumatology Unit, la Cavale Blanche Hospital, Brest Teaching Hospital, BP 814, F 29609 Brest-Cedex, France. E-mail: Alain.Saraux@univ-brest.fr Accepted for publication November 27, 2012.
Damien Loeuille
From Rheumatology, Centre Hospitalier Universitaire (CHU) Brest, Brest; Statistics, RCTS, Lyon; Rheumatology, CHU, Rennes; Rheumatology, CHU, Grenoble; Rheumatology, APHP, Paris Boulogne; Rheumatology, CHU, Nancy; Rheumatology, CHU, Paris Saint Antoine; Rheumatology, CHU, Paris Boulogne; Rheumatology, CHU, Pitié, Paris; Rheumatology, APHP, Cochin, Paris, France; and Rheumatology, CHU, Brugmann, Belgium. Supported by an unrestricted grant from Abbott France. M. Le Boedec, MD; S. Jousse-Joulin, MD, Rheumatology, CHU Brest; JF. Ferlet, PhD, Statistics, RCTS; T. Marhadour, MD, Rheumatology, CHU Brest; G. Chales, MD, Rheumatology, CHU, Rennes; L. Grange, MD, Rheumatology, CHU, Grenoble; C. Hacquard-Bouder, MD, Rheumatology, APHP, Paris Boulogne; D. Loeuille, MD, PhD, Rheumatology, CHU, Nancy; J. Sellam, MD, PhD, Rheumatology, CHU, Paris Saint Antoine; J-D. Albert, MD, Rheumatology, CHU, Rennes; J. Bentin, MD, Rheumatology, CHU, Brugmann; I. Chary-Valckenaere, MD, PhD, Rheumatology, CHU, Nancy; M-A. d’Agostino, MD, PhD, Rheumatology, CHU, Paris Boulogne; F. Etchepare, MD, Rheumatology, CHU, Pitié, Paris; P. Gaudin, MD, PhD, Rheumatology, CHU, Grenoble; C. Hudry, MD; M. Dougados, MD, Rheumatology, APHP, Cochin, Paris; A. Saraux, MD, PhD, Rheumatology, CHU Brest. Dr. M. Le Boedec and Dr. S. Jousse-Joulin contributed equally to this report. Address correspondence to Prof. A. Saraux, Rheumatology Unit, la Cavale Blanche Hospital, Brest Teaching Hospital, BP 814, F 29609 Brest-Cedex, France. E-mail: Alain.Saraux@univ-brest.fr Accepted for publication November 27, 2012.
Jérémie Sellam
From Rheumatology, Centre Hospitalier Universitaire (CHU) Brest, Brest; Statistics, RCTS, Lyon; Rheumatology, CHU, Rennes; Rheumatology, CHU, Grenoble; Rheumatology, APHP, Paris Boulogne; Rheumatology, CHU, Nancy; Rheumatology, CHU, Paris Saint Antoine; Rheumatology, CHU, Paris Boulogne; Rheumatology, CHU, Pitié, Paris; Rheumatology, APHP, Cochin, Paris, France; and Rheumatology, CHU, Brugmann, Belgium. Supported by an unrestricted grant from Abbott France. M. Le Boedec, MD; S. Jousse-Joulin, MD, Rheumatology, CHU Brest; JF. Ferlet, PhD, Statistics, RCTS; T. Marhadour, MD, Rheumatology, CHU Brest; G. Chales, MD, Rheumatology, CHU, Rennes; L. Grange, MD, Rheumatology, CHU, Grenoble; C. Hacquard-Bouder, MD, Rheumatology, APHP, Paris Boulogne; D. Loeuille, MD, PhD, Rheumatology, CHU, Nancy; J. Sellam, MD, PhD, Rheumatology, CHU, Paris Saint Antoine; J-D. Albert, MD, Rheumatology, CHU, Rennes; J. Bentin, MD, Rheumatology, CHU, Brugmann; I. Chary-Valckenaere, MD, PhD, Rheumatology, CHU, Nancy; M-A. d’Agostino, MD, PhD, Rheumatology, CHU, Paris Boulogne; F. Etchepare, MD, Rheumatology, CHU, Pitié, Paris; P. Gaudin, MD, PhD, Rheumatology, CHU, Grenoble; C. Hudry, MD; M. Dougados, MD, Rheumatology, APHP, Cochin, Paris; A. Saraux, MD, PhD, Rheumatology, CHU Brest. Dr. M. Le Boedec and Dr. S. Jousse-Joulin contributed equally to this report. Address correspondence to Prof. A. Saraux, Rheumatology Unit, la Cavale Blanche Hospital, Brest Teaching Hospital, BP 814, F 29609 Brest-Cedex, France. E-mail: Alain.Saraux@univ-brest.fr Accepted for publication November 27, 2012.
Jean-David Albert
From Rheumatology, Centre Hospitalier Universitaire (CHU) Brest, Brest; Statistics, RCTS, Lyon; Rheumatology, CHU, Rennes; Rheumatology, CHU, Grenoble; Rheumatology, APHP, Paris Boulogne; Rheumatology, CHU, Nancy; Rheumatology, CHU, Paris Saint Antoine; Rheumatology, CHU, Paris Boulogne; Rheumatology, CHU, Pitié, Paris; Rheumatology, APHP, Cochin, Paris, France; and Rheumatology, CHU, Brugmann, Belgium. Supported by an unrestricted grant from Abbott France. M. Le Boedec, MD; S. Jousse-Joulin, MD, Rheumatology, CHU Brest; JF. Ferlet, PhD, Statistics, RCTS; T. Marhadour, MD, Rheumatology, CHU Brest; G. Chales, MD, Rheumatology, CHU, Rennes; L. Grange, MD, Rheumatology, CHU, Grenoble; C. Hacquard-Bouder, MD, Rheumatology, APHP, Paris Boulogne; D. Loeuille, MD, PhD, Rheumatology, CHU, Nancy; J. Sellam, MD, PhD, Rheumatology, CHU, Paris Saint Antoine; J-D. Albert, MD, Rheumatology, CHU, Rennes; J. Bentin, MD, Rheumatology, CHU, Brugmann; I. Chary-Valckenaere, MD, PhD, Rheumatology, CHU, Nancy; M-A. d’Agostino, MD, PhD, Rheumatology, CHU, Paris Boulogne; F. Etchepare, MD, Rheumatology, CHU, Pitié, Paris; P. Gaudin, MD, PhD, Rheumatology, CHU, Grenoble; C. Hudry, MD; M. Dougados, MD, Rheumatology, APHP, Cochin, Paris; A. Saraux, MD, PhD, Rheumatology, CHU Brest. Dr. M. Le Boedec and Dr. S. Jousse-Joulin contributed equally to this report. Address correspondence to Prof. A. Saraux, Rheumatology Unit, la Cavale Blanche Hospital, Brest Teaching Hospital, BP 814, F 29609 Brest-Cedex, France. E-mail: Alain.Saraux@univ-brest.fr Accepted for publication November 27, 2012.
Jacques Bentin
From Rheumatology, Centre Hospitalier Universitaire (CHU) Brest, Brest; Statistics, RCTS, Lyon; Rheumatology, CHU, Rennes; Rheumatology, CHU, Grenoble; Rheumatology, APHP, Paris Boulogne; Rheumatology, CHU, Nancy; Rheumatology, CHU, Paris Saint Antoine; Rheumatology, CHU, Paris Boulogne; Rheumatology, CHU, Pitié, Paris; Rheumatology, APHP, Cochin, Paris, France; and Rheumatology, CHU, Brugmann, Belgium. Supported by an unrestricted grant from Abbott France. M. Le Boedec, MD; S. Jousse-Joulin, MD, Rheumatology, CHU Brest; JF. Ferlet, PhD, Statistics, RCTS; T. Marhadour, MD, Rheumatology, CHU Brest; G. Chales, MD, Rheumatology, CHU, Rennes; L. Grange, MD, Rheumatology, CHU, Grenoble; C. Hacquard-Bouder, MD, Rheumatology, APHP, Paris Boulogne; D. Loeuille, MD, PhD, Rheumatology, CHU, Nancy; J. Sellam, MD, PhD, Rheumatology, CHU, Paris Saint Antoine; J-D. Albert, MD, Rheumatology, CHU, Rennes; J. Bentin, MD, Rheumatology, CHU, Brugmann; I. Chary-Valckenaere, MD, PhD, Rheumatology, CHU, Nancy; M-A. d’Agostino, MD, PhD, Rheumatology, CHU, Paris Boulogne; F. Etchepare, MD, Rheumatology, CHU, Pitié, Paris; P. Gaudin, MD, PhD, Rheumatology, CHU, Grenoble; C. Hudry, MD; M. Dougados, MD, Rheumatology, APHP, Cochin, Paris; A. Saraux, MD, PhD, Rheumatology, CHU Brest. Dr. M. Le Boedec and Dr. S. Jousse-Joulin contributed equally to this report. Address correspondence to Prof. A. Saraux, Rheumatology Unit, la Cavale Blanche Hospital, Brest Teaching Hospital, BP 814, F 29609 Brest-Cedex, France. E-mail: Alain.Saraux@univ-brest.fr Accepted for publication November 27, 2012.
Isabelle Chary-Valckenaere
From Rheumatology, Centre Hospitalier Universitaire (CHU) Brest, Brest; Statistics, RCTS, Lyon; Rheumatology, CHU, Rennes; Rheumatology, CHU, Grenoble; Rheumatology, APHP, Paris Boulogne; Rheumatology, CHU, Nancy; Rheumatology, CHU, Paris Saint Antoine; Rheumatology, CHU, Paris Boulogne; Rheumatology, CHU, Pitié, Paris; Rheumatology, APHP, Cochin, Paris, France; and Rheumatology, CHU, Brugmann, Belgium. Supported by an unrestricted grant from Abbott France. M. Le Boedec, MD; S. Jousse-Joulin, MD, Rheumatology, CHU Brest; JF. Ferlet, PhD, Statistics, RCTS; T. Marhadour, MD, Rheumatology, CHU Brest; G. Chales, MD, Rheumatology, CHU, Rennes; L. Grange, MD, Rheumatology, CHU, Grenoble; C. Hacquard-Bouder, MD, Rheumatology, APHP, Paris Boulogne; D. Loeuille, MD, PhD, Rheumatology, CHU, Nancy; J. Sellam, MD, PhD, Rheumatology, CHU, Paris Saint Antoine; J-D. Albert, MD, Rheumatology, CHU, Rennes; J. Bentin, MD, Rheumatology, CHU, Brugmann; I. Chary-Valckenaere, MD, PhD, Rheumatology, CHU, Nancy; M-A. d’Agostino, MD, PhD, Rheumatology, CHU, Paris Boulogne; F. Etchepare, MD, Rheumatology, CHU, Pitié, Paris; P. Gaudin, MD, PhD, Rheumatology, CHU, Grenoble; C. Hudry, MD; M. Dougados, MD, Rheumatology, APHP, Cochin, Paris; A. Saraux, MD, PhD, Rheumatology, CHU Brest. Dr. M. Le Boedec and Dr. S. Jousse-Joulin contributed equally to this report. Address correspondence to Prof. A. Saraux, Rheumatology Unit, la Cavale Blanche Hospital, Brest Teaching Hospital, BP 814, F 29609 Brest-Cedex, France. E-mail: Alain.Saraux@univ-brest.fr Accepted for publication November 27, 2012.
Maria-Antonietta d'Agostino
From Rheumatology, Centre Hospitalier Universitaire (CHU) Brest, Brest; Statistics, RCTS, Lyon; Rheumatology, CHU, Rennes; Rheumatology, CHU, Grenoble; Rheumatology, APHP, Paris Boulogne; Rheumatology, CHU, Nancy; Rheumatology, CHU, Paris Saint Antoine; Rheumatology, CHU, Paris Boulogne; Rheumatology, CHU, Pitié, Paris; Rheumatology, APHP, Cochin, Paris, France; and Rheumatology, CHU, Brugmann, Belgium. Supported by an unrestricted grant from Abbott France. M. Le Boedec, MD; S. Jousse-Joulin, MD, Rheumatology, CHU Brest; JF. Ferlet, PhD, Statistics, RCTS; T. Marhadour, MD, Rheumatology, CHU Brest; G. Chales, MD, Rheumatology, CHU, Rennes; L. Grange, MD, Rheumatology, CHU, Grenoble; C. Hacquard-Bouder, MD, Rheumatology, APHP, Paris Boulogne; D. Loeuille, MD, PhD, Rheumatology, CHU, Nancy; J. Sellam, MD, PhD, Rheumatology, CHU, Paris Saint Antoine; J-D. Albert, MD, Rheumatology, CHU, Rennes; J. Bentin, MD, Rheumatology, CHU, Brugmann; I. Chary-Valckenaere, MD, PhD, Rheumatology, CHU, Nancy; M-A. d’Agostino, MD, PhD, Rheumatology, CHU, Paris Boulogne; F. Etchepare, MD, Rheumatology, CHU, Pitié, Paris; P. Gaudin, MD, PhD, Rheumatology, CHU, Grenoble; C. Hudry, MD; M. Dougados, MD, Rheumatology, APHP, Cochin, Paris; A. Saraux, MD, PhD, Rheumatology, CHU Brest. Dr. M. Le Boedec and Dr. S. Jousse-Joulin contributed equally to this report. Address correspondence to Prof. A. Saraux, Rheumatology Unit, la Cavale Blanche Hospital, Brest Teaching Hospital, BP 814, F 29609 Brest-Cedex, France. E-mail: Alain.Saraux@univ-brest.fr Accepted for publication November 27, 2012.
Fabien Etchepare
From Rheumatology, Centre Hospitalier Universitaire (CHU) Brest, Brest; Statistics, RCTS, Lyon; Rheumatology, CHU, Rennes; Rheumatology, CHU, Grenoble; Rheumatology, APHP, Paris Boulogne; Rheumatology, CHU, Nancy; Rheumatology, CHU, Paris Saint Antoine; Rheumatology, CHU, Paris Boulogne; Rheumatology, CHU, Pitié, Paris; Rheumatology, APHP, Cochin, Paris, France; and Rheumatology, CHU, Brugmann, Belgium. Supported by an unrestricted grant from Abbott France. M. Le Boedec, MD; S. Jousse-Joulin, MD, Rheumatology, CHU Brest; JF. Ferlet, PhD, Statistics, RCTS; T. Marhadour, MD, Rheumatology, CHU Brest; G. Chales, MD, Rheumatology, CHU, Rennes; L. Grange, MD, Rheumatology, CHU, Grenoble; C. Hacquard-Bouder, MD, Rheumatology, APHP, Paris Boulogne; D. Loeuille, MD, PhD, Rheumatology, CHU, Nancy; J. Sellam, MD, PhD, Rheumatology, CHU, Paris Saint Antoine; J-D. Albert, MD, Rheumatology, CHU, Rennes; J. Bentin, MD, Rheumatology, CHU, Brugmann; I. Chary-Valckenaere, MD, PhD, Rheumatology, CHU, Nancy; M-A. d’Agostino, MD, PhD, Rheumatology, CHU, Paris Boulogne; F. Etchepare, MD, Rheumatology, CHU, Pitié, Paris; P. Gaudin, MD, PhD, Rheumatology, CHU, Grenoble; C. Hudry, MD; M. Dougados, MD, Rheumatology, APHP, Cochin, Paris; A. Saraux, MD, PhD, Rheumatology, CHU Brest. Dr. M. Le Boedec and Dr. S. Jousse-Joulin contributed equally to this report. Address correspondence to Prof. A. Saraux, Rheumatology Unit, la Cavale Blanche Hospital, Brest Teaching Hospital, BP 814, F 29609 Brest-Cedex, France. E-mail: Alain.Saraux@univ-brest.fr Accepted for publication November 27, 2012.
Philippe Gaudin
From Rheumatology, Centre Hospitalier Universitaire (CHU) Brest, Brest; Statistics, RCTS, Lyon; Rheumatology, CHU, Rennes; Rheumatology, CHU, Grenoble; Rheumatology, APHP, Paris Boulogne; Rheumatology, CHU, Nancy; Rheumatology, CHU, Paris Saint Antoine; Rheumatology, CHU, Paris Boulogne; Rheumatology, CHU, Pitié, Paris; Rheumatology, APHP, Cochin, Paris, France; and Rheumatology, CHU, Brugmann, Belgium. Supported by an unrestricted grant from Abbott France. M. Le Boedec, MD; S. Jousse-Joulin, MD, Rheumatology, CHU Brest; JF. Ferlet, PhD, Statistics, RCTS; T. Marhadour, MD, Rheumatology, CHU Brest; G. Chales, MD, Rheumatology, CHU, Rennes; L. Grange, MD, Rheumatology, CHU, Grenoble; C. Hacquard-Bouder, MD, Rheumatology, APHP, Paris Boulogne; D. Loeuille, MD, PhD, Rheumatology, CHU, Nancy; J. Sellam, MD, PhD, Rheumatology, CHU, Paris Saint Antoine; J-D. Albert, MD, Rheumatology, CHU, Rennes; J. Bentin, MD, Rheumatology, CHU, Brugmann; I. Chary-Valckenaere, MD, PhD, Rheumatology, CHU, Nancy; M-A. d’Agostino, MD, PhD, Rheumatology, CHU, Paris Boulogne; F. Etchepare, MD, Rheumatology, CHU, Pitié, Paris; P. Gaudin, MD, PhD, Rheumatology, CHU, Grenoble; C. Hudry, MD; M. Dougados, MD, Rheumatology, APHP, Cochin, Paris; A. Saraux, MD, PhD, Rheumatology, CHU Brest. Dr. M. Le Boedec and Dr. S. Jousse-Joulin contributed equally to this report. Address correspondence to Prof. A. Saraux, Rheumatology Unit, la Cavale Blanche Hospital, Brest Teaching Hospital, BP 814, F 29609 Brest-Cedex, France. E-mail: Alain.Saraux@univ-brest.fr Accepted for publication November 27, 2012.
Christophe Hudry
From Rheumatology, Centre Hospitalier Universitaire (CHU) Brest, Brest; Statistics, RCTS, Lyon; Rheumatology, CHU, Rennes; Rheumatology, CHU, Grenoble; Rheumatology, APHP, Paris Boulogne; Rheumatology, CHU, Nancy; Rheumatology, CHU, Paris Saint Antoine; Rheumatology, CHU, Paris Boulogne; Rheumatology, CHU, Pitié, Paris; Rheumatology, APHP, Cochin, Paris, France; and Rheumatology, CHU, Brugmann, Belgium. Supported by an unrestricted grant from Abbott France. M. Le Boedec, MD; S. Jousse-Joulin, MD, Rheumatology, CHU Brest; JF. Ferlet, PhD, Statistics, RCTS; T. Marhadour, MD, Rheumatology, CHU Brest; G. Chales, MD, Rheumatology, CHU, Rennes; L. Grange, MD, Rheumatology, CHU, Grenoble; C. Hacquard-Bouder, MD, Rheumatology, APHP, Paris Boulogne; D. Loeuille, MD, PhD, Rheumatology, CHU, Nancy; J. Sellam, MD, PhD, Rheumatology, CHU, Paris Saint Antoine; J-D. Albert, MD, Rheumatology, CHU, Rennes; J. Bentin, MD, Rheumatology, CHU, Brugmann; I. Chary-Valckenaere, MD, PhD, Rheumatology, CHU, Nancy; M-A. d’Agostino, MD, PhD, Rheumatology, CHU, Paris Boulogne; F. Etchepare, MD, Rheumatology, CHU, Pitié, Paris; P. Gaudin, MD, PhD, Rheumatology, CHU, Grenoble; C. Hudry, MD; M. Dougados, MD, Rheumatology, APHP, Cochin, Paris; A. Saraux, MD, PhD, Rheumatology, CHU Brest. Dr. M. Le Boedec and Dr. S. Jousse-Joulin contributed equally to this report. Address correspondence to Prof. A. Saraux, Rheumatology Unit, la Cavale Blanche Hospital, Brest Teaching Hospital, BP 814, F 29609 Brest-Cedex, France. E-mail: Alain.Saraux@univ-brest.fr Accepted for publication November 27, 2012.
Maxime Dougados
From Rheumatology, Centre Hospitalier Universitaire (CHU) Brest, Brest; Statistics, RCTS, Lyon; Rheumatology, CHU, Rennes; Rheumatology, CHU, Grenoble; Rheumatology, APHP, Paris Boulogne; Rheumatology, CHU, Nancy; Rheumatology, CHU, Paris Saint Antoine; Rheumatology, CHU, Paris Boulogne; Rheumatology, CHU, Pitié, Paris; Rheumatology, APHP, Cochin, Paris, France; and Rheumatology, CHU, Brugmann, Belgium. Supported by an unrestricted grant from Abbott France. M. Le Boedec, MD; S. Jousse-Joulin, MD, Rheumatology, CHU Brest; JF. Ferlet, PhD, Statistics, RCTS; T. Marhadour, MD, Rheumatology, CHU Brest; G. Chales, MD, Rheumatology, CHU, Rennes; L. Grange, MD, Rheumatology, CHU, Grenoble; C. Hacquard-Bouder, MD, Rheumatology, APHP, Paris Boulogne; D. Loeuille, MD, PhD, Rheumatology, CHU, Nancy; J. Sellam, MD, PhD, Rheumatology, CHU, Paris Saint Antoine; J-D. Albert, MD, Rheumatology, CHU, Rennes; J. Bentin, MD, Rheumatology, CHU, Brugmann; I. Chary-Valckenaere, MD, PhD, Rheumatology, CHU, Nancy; M-A. d’Agostino, MD, PhD, Rheumatology, CHU, Paris Boulogne; F. Etchepare, MD, Rheumatology, CHU, Pitié, Paris; P. Gaudin, MD, PhD, Rheumatology, CHU, Grenoble; C. Hudry, MD; M. Dougados, MD, Rheumatology, APHP, Cochin, Paris; A. Saraux, MD, PhD, Rheumatology, CHU Brest. Dr. M. Le Boedec and Dr. S. Jousse-Joulin contributed equally to this report. Address correspondence to Prof. A. Saraux, Rheumatology Unit, la Cavale Blanche Hospital, Brest Teaching Hospital, BP 814, F 29609 Brest-Cedex, France. E-mail: Alain.Saraux@univ-brest.fr Accepted for publication November 27, 2012.
Alain Saraux
From Rheumatology, Centre Hospitalier Universitaire (CHU) Brest, Brest; Statistics, RCTS, Lyon; Rheumatology, CHU, Rennes; Rheumatology, CHU, Grenoble; Rheumatology, APHP, Paris Boulogne; Rheumatology, CHU, Nancy; Rheumatology, CHU, Paris Saint Antoine; Rheumatology, CHU, Paris Boulogne; Rheumatology, CHU, Pitié, Paris; Rheumatology, APHP, Cochin, Paris, France; and Rheumatology, CHU, Brugmann, Belgium. Supported by an unrestricted grant from Abbott France. M. Le Boedec, MD; S. Jousse-Joulin, MD, Rheumatology, CHU Brest; JF. Ferlet, PhD, Statistics, RCTS; T. Marhadour, MD, Rheumatology, CHU Brest; G. Chales, MD, Rheumatology, CHU, Rennes; L. Grange, MD, Rheumatology, CHU, Grenoble; C. Hacquard-Bouder, MD, Rheumatology, APHP, Paris Boulogne; D. Loeuille, MD, PhD, Rheumatology, CHU, Nancy; J. Sellam, MD, PhD, Rheumatology, CHU, Paris Saint Antoine; J-D. Albert, MD, Rheumatology, CHU, Rennes; J. Bentin, MD, Rheumatology, CHU, Brugmann; I. Chary-Valckenaere, MD, PhD, Rheumatology, CHU, Nancy; M-A. d’Agostino, MD, PhD, Rheumatology, CHU, Paris Boulogne; F. Etchepare, MD, Rheumatology, CHU, Pitié, Paris; P. Gaudin, MD, PhD, Rheumatology, CHU, Grenoble; C. Hudry, MD; M. Dougados, MD, Rheumatology, APHP, Cochin, Paris; A. Saraux, MD, PhD, Rheumatology, CHU Brest. Dr. M. Le Boedec and Dr. S. Jousse-Joulin contributed equally to this report. Address correspondence to Prof. A. Saraux, Rheumatology Unit, la Cavale Blanche Hospital, Brest Teaching Hospital, BP 814, F 29609 Brest-Cedex, France. E-mail: Alain.Saraux@univ-brest.fr Accepted for publication November 27, 2012.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Factors Influencing Concordance Between Clinical and Ultrasound Findings in Rheumatoid Arthritis
Marion Le Boedec, Sandrine Jousse-Joulin, Jean-François Ferlet, Thierry Marhadour, Gérard Chales, Laurent Grange, Cécile Hacquard-Bouder, Damien Loeuille, Jérémie Sellam, Jean-David Albert, Jacques Bentin, Isabelle Chary-Valckenaere, Maria-Antonietta d'Agostino, Fabien Etchepare, Philippe Gaudin, Christophe Hudry, Maxime Dougados, Alain Saraux
The Journal of Rheumatology Jan 2013, jrheum.120843; DOI: 10.3899/jrheum.120843
Factors Influencing Concordance Between Clinical and Ultrasound Findings in Rheumatoid Arthritis
Marion Le Boedec, Sandrine Jousse-Joulin, Jean-François Ferlet, Thierry Marhadour, Gérard Chales, Laurent Grange, Cécile Hacquard-Bouder, Damien Loeuille, Jérémie Sellam, Jean-David Albert, Jacques Bentin, Isabelle Chary-Valckenaere, Maria-Antonietta d'Agostino, Fabien Etchepare, Philippe Gaudin, Christophe Hudry, Maxime Dougados, Alain Saraux
The Journal of Rheumatology Jan 2013, jrheum.120843; DOI: 10.3899/jrheum.120843